GSK Plc

Latest in GSK plc

Moderna shares plunge on plans to cut $1.1 billion in costs, launch 10 new products by 2027
by thinkia.org.in 7 months ago
Moderna headquarters, exterior view, Cambridge, Massachusetts, USA. Plexi Images | GHI | UCG | Universal Images Group | Getty Images Moderna …
Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market
by thinkia.org.in 8 months ago
Moderna on Thursday reported second-quarter revenue that beat expectations but slashed its full-year sales guidance, citing lower expected sales in …
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
by thinkia.org.in 9 months ago
Kena Betancur | Corbis News | Getty Images Pfizer had a “phenomenal” first quarter — and Wall Street took notice, …
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
by thinkia.org.in 10 months ago
Zoom In IconArrows pointing outwards Merck’s new pneumococcal vaccine. Courtesy: Merck The Food and Drug Administration on Monday approved Merck‘s …
FDA approves Moderna’s RSV vaccine for seniors, the company’s second-ever product
by thinkia.org.in 10 months ago
Nikos Pekiaridis | Lightrocket | Getty Images The Food and Drug Administration on Friday approved Moderna’s vaccine for respiratory syncytial …
Moderna says FDA delayed RSV vaccine approval to end of May
by thinkia.org.in 11 months ago
Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Friday said the Food and Drug Administration has delayed the approval …
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
by thinkia.org.in 1 year ago
The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, January 19, 2024. Staff …

Vaccine stocks fall as Senate panel advances RFK Jr.’s nomination for HHS secretary

Pharma is hopeful about Trump’s second term — here’s what to expect for drugmakers

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

Vaccine maker stocks fall as Trump chooses RFK Jr. to lead HHS

Merck says experimental RSV treatment protected infants in trial, paving way for potential approval

Latest in GSK plc

Moderna shares plunge on plans to cut $1.1 billion in costs, launch 10 new products by 2027

Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market

Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline

FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections

FDA approves Moderna’s RSV vaccine for seniors, the company’s second-ever product

Moderna says FDA delayed RSV vaccine approval to end of May

The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons

Editors' Picks

Google might’ve accidentally approved an ad for a Target gift card scam

Latest Posts

Follow us